Physician profile
David A Halio
NPI 1700963386
$2,679.80
in general payments reported to CMS, 2019-2025
17 companies · $447 in 2025
The $447 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2021: $97.23 · 2022: $716 · 2023: $775 · 2024: $323 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,544.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $536.03 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $381.76 | 2022-2025 | |
| Myovant Sciences INC. | $281.41 | 2022 | |
| Sumitomo Pharma America, INC. | $224.41 | 2023-2025 | Myfembree |
| Intra-Sana Laboratories | $166.67 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Gynesonics, INC. | $132.74 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astrazeneca Pharmaceuticals LP | $125.42 | 2023 | Andexxa |
| Ascend Therapeutics US, LLC | $125.00 | 2023 | |
| Lilly USA, LLC | $125.00 | 2024 | Zepbound |
| Vivus LLC | $124.97 | 2023 | Qsymia |
| Glaxosmithkline, LLC. | $122.91 | 2023 | Arexvy |
| Novo Nordisk INC | $122.43 | 2023 | Wegovy |
| Amag Pharmaceuticals, INC. | $118.73 | 2019 | |
| Coopersurgical, INC. | $38.12 | 2022-2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $21.43 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $17.26 | 2025 | Apretude |
| Avion Pharmaceuticals | $15.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Halio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.